Adlai Nortye (ANL) Notes Payables (2022 - 2025)

Adlai Nortye (ANL) reported Notes Payables of $24.6 million for Q4 2025, down 6.64% year-over-year from $26.3 million in Q4 2024, and down 6.64% on a QoQ basis from $26.3 million in Q4 2024.

Adlai Nortye (ANL) has 4 years of Notes Payables data on file, last reported at $24.6 million in Q4 2025.

  • Quarterly Notes Payables fell 6.64% year-over-year to $24.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $24.6 million (down 6.64% YoY) and the FY2025 annual result came in at $24.6 million, down 6.64% from the prior year.
  • Notes Payables eased to $24.6 million in Q4 2025 per ANL's latest filing, from $26.3 million in the prior quarter.
  • Across five years, Notes Payables topped out at $30.4 million in Q4 2023 and bottomed at $4.3 million in Q4 2022.
  • The 4-year median for Notes Payables is $25.5 million (2024), against an average of $21.4 million.
  • The widest annual swing landed in 2023, when Notes Payables jumped 604.83%; it then dropped 13.27% in 2024.
  • Tracing ANL's Notes Payables over 4 years: stood at $4.3 million in 2022, then jumped by 604.83% to $30.4 million in 2023, then slipped by 13.27% to $26.3 million in 2024, then retreated by 6.64% to $24.6 million in 2025.
  • Per Business Quant, the three latest ANL Notes Payables figures stand at $24.6 million (Q4 2025), $26.3 million (Q4 2024), and $30.4 million (Q4 2023).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 1,638,563.89 Bn 1,638,563.89 Bn -
2 Alterity Therapeutics 767,934.24 Bn 767,934.20 Bn -
3 Legend Biotech 2,937.00 Bn 2,936.10 Bn 242.10 Mn
4 Nanobiotix 2,282.79 Bn 2,282.72 Bn -
5 Akari Therapeutics 2,169.69 Bn 2,169.69 Bn -
6 Vertex Pharmaceuticals 110.41 Bn 103.16 Bn 2.59 Bn
7 Regeneron Pharmaceuticals 66.44 Bn 57.69 Bn 3.31 Bn
8 Evaxion A 65.44 Bn 65.42 Bn -
9 Alnylam Pharmaceuticals 39.53 Bn 36.52 Bn 959.66 Mn
10 Adlai Nortye 23,840.00 -8.03 Mn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 24.58 Mn
Dec 31, 2024 26.33 Mn
Dec 31, 2023 30.36 Mn
Dec 31, 2022 4.31 Mn